{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:25:56Z","timestamp":1783520756977,"version":"3.55.0"},"reference-count":53,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2026,2,17]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>Group B Streptococcus (GBS) remains a leading cause of neonatal sepsis and meningitis in the UK, with an incidence of around 0.9 per 1000 live births. Early-onset disease usually results from vertical transmission during delivery, while late-onset disease is also acquired through postnatal exposures. GBS disease presents as sepsis, meningitis or pneumonia and leads to death in 6% of affected infants and long-term neurodevelopmental impairment in up to a third of survivors. The current UK prevention strategy of risk-based intra-partum antibiotic prophylaxis has several limitations, including lack of impact on disease burden in infants without associated risk factors and on late-onset disease. Ongoing studies of universal antenatal GBS screening and GBS maternal immunisations, along with a new British Paediatric Surveillance Unit surveillance study to provide updated epidemiological data will help to guide policy and practice.<\/jats:p>","DOI":"10.1136\/archdischild-2025-330108","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:20:20Z","timestamp":1773681620000},"page":"F310-F315","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Current knowledge and future perspectives on management and prevention of group B streptococcus in neonates and young infants"],"prefix":"10.1136","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5579-4675","authenticated-orcid":false,"given":"Andrew N","family":"Young","sequence":"first","affiliation":[{"name":"Institute for Infection and Immunity, City St George\u2019s University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Karampatsas","sequence":"additional","affiliation":[{"name":"Institute for Infection and Immunity, City St George\u2019s University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0856-2476","authenticated-orcid":false,"given":"Shamez N","family":"Ladhani","sequence":"additional","affiliation":[{"name":"Institute for Infection and Immunity, City St George\u2019s University of London, London, UK"},{"name":"UK Health Security Agency, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa L","family":"Lamagni","sequence":"additional","affiliation":[{"name":"Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use, and Sepsis Division, UK Health Security Agency, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Le Doare","sequence":"additional","affiliation":[{"name":"Institute for Infection and Immunity, City St George\u2019s University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Peacock","sequence":"additional","affiliation":[{"name":"Institute for Infection and Immunity, City St George\u2019s University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Thorn","sequence":"additional","affiliation":[{"name":"Institute for Infection and Immunity, City St George\u2019s University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7540-7433","authenticated-orcid":false,"given":"Paul T","family":"Heath","sequence":"additional","affiliation":[{"name":"Institute for Infection and Immunity, City St George\u2019s University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"2026070807100833000_111.4.F310.1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix658"},{"key":"2026070807100833000_111.4.F310.2","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15648"},{"key":"2026070807100833000_111.4.F310.3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098778","article-title":"Serotype-specific acquisition and loss of group B streptococcus recto-vaginal colonization in late pregnancy","volume":"9","author":"Kwatra","year":"2014","journal-title":"PLoS ONE"},{"key":"2026070807100833000_111.4.F310.4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix660"},{"key":"2026070807100833000_111.4.F310.5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/1471-0528.16852","article-title":"Assessing the added value of group B Streptococcus maternal immunisation in preventing maternal infection and fetal harm: population surveillance study","volume":"129","author":"Lamagni","year":"2022","journal-title":"BJOG"},{"key":"2026070807100833000_111.4.F310.6","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1097\/INF.0000000000002050","article-title":"Bacterial Load and Molecular Markers Associated With Early-onset Group B Streptococcus: A Systematic Review and Meta-analysis","volume":"37","author":"Seedat","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"2026070807100833000_111.4.F310.7","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.14821"},{"key":"2026070807100833000_111.4.F310.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30555-3"},{"key":"2026070807100833000_111.4.F310.9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix656"},{"key":"2026070807100833000_111.4.F310.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15389-5"},{"key":"2026070807100833000_111.4.F310.11","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-056080","article-title":"Race and Ethnicity in Neonatal Group B Streptococcal Disease in England: 2016-2020","volume":"150","author":"Collin","year":"2022","journal-title":"Pediatrics"},{"key":"2026070807100833000_111.4.F310.12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac206"},{"key":"2026070807100833000_111.4.F310.13","unstructured":"National Institute for Health and Care Excellence (NICE) . Neonatal infection: antibiotics for prevention and treatment (NG195). 2024. Available: https:\/\/www.nice.org.uk\/guidance\/ng195"},{"key":"2026070807100833000_111.4.F310.14","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/cid\/ciz033","article-title":"Risk Factors for Infant Colonization by Hypervirulent CC17 Group B Streptococcus: Toward the Understanding of Late-onset Disease","volume":"69","author":"Tazi","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026070807100833000_111.4.F310.15","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-049561","article-title":"Breastfeeding and Risk of Late-Onset Group B Streptococcal Disease","volume":"148","author":"Ching","year":"2021","journal-title":"Pediatrics"},{"key":"2026070807100833000_111.4.F310.16","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1093\/cid\/ciaa1087","article-title":"Uncovering Infant Group B Streptococcal (GBS) Disease Clusters in the United Kingdom and Ireland Through Genomic Analysis: A Population-based Epidemiological Study","volume":"72","author":"Collin","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026070807100833000_111.4.F310.17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jinf.2019.11.008","article-title":"Hospital clusters of invasive Group B Streptococcal disease: A systematic review","volume":"79","author":"Collin","year":"2019","journal-title":"J Infect"},{"key":"2026070807100833000_111.4.F310.18","unstructured":"UKHSA . Public health microbiology laboratories colindale: bacteriology reference department user manual 2024. 2024."},{"key":"2026070807100833000_111.4.F310.19","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01424-08"},{"key":"2026070807100833000_111.4.F310.20","doi-asserted-by":"crossref","DOI":"10.1172\/JCI136737","article-title":"CC17 group B Streptococcus exploits integrins for neonatal meningitis development","volume":"131","author":"Deshayes de Cambronne","year":"2021","journal-title":"J Clin Invest"},{"key":"2026070807100833000_111.4.F310.21","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae419"},{"key":"2026070807100833000_111.4.F310.22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191193","article-title":"Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015","volume":"13","author":"Siga\u00faque","year":"2018","journal-title":"PLoS One"},{"key":"2026070807100833000_111.4.F310.23","unstructured":"World Health Organization . WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. 2024."},{"key":"2026070807100833000_111.4.F310.24","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa634","article-title":"Low but Increasing Prevalence of Reduced Beta-lactam Susceptibility Among Invasive Group B Streptococcal Isolates, US Population-Based Surveillance, 1998-2018","volume":"8","author":"Kobayashi","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2026070807100833000_111.4.F310.25","unstructured":"UKHSA . Laboratory surveillance of streptococcal bacteraemia in England. Report no.: health protection report volume 18 number 11. 2023."},{"key":"2026070807100833000_111.4.F310.26","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(22)00093-6"},{"key":"2026070807100833000_111.4.F310.27","unstructured":"MBRRACE-UK collaboration . MBRRACE-UK perinatal mortality surveillance report (2020). 2022."},{"key":"2026070807100833000_111.4.F310.28","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad356","article-title":"Stillbirths and Neonatal Deaths Caused by Group B Streptococcus in Africa and South Asia Identified Through Child Health and Mortality Prevention Surveillance (CHAMPS)","volume":"10","author":"Mahtab","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026070807100833000_111.4.F310.29","doi-asserted-by":"crossref","unstructured":"Ogunlesi TA , Odigwe CC , Oladapo OT . Adjuvant corticosteroids for reducing death in neonatal bacterial meningitis - Ogunlesi, TA. Cochrane Library; 2015. Available: https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD010435.pub2\/full [Accessed 28 Aug 2025].","DOI":"10.1002\/14651858.CD010435.pub2"},{"key":"2026070807100833000_111.4.F310.30","unstructured":"Better outcomes in babies with bacterial meningitis: BOBBi. NIHR Funding and Awards. Available: https:\/\/www.fundingawards.nihr.ac.uk\/award\/NIHR166133 [Accessed 30 Sep 2025]."},{"key":"2026070807100833000_111.4.F310.31","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2022-324380"},{"key":"2026070807100833000_111.4.F310.32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-072708","article-title":"Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020-2021","volume":"13","author":"Piyasena","year":"2023","journal-title":"BMJ Open"},{"key":"2026070807100833000_111.4.F310.33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/14787210.2025.2474569","article-title":"Recurrence of group B streptococcal infections in infants: a systematic review","volume":"23","author":"Miselli","year":"2025","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2026070807100833000_111.4.F310.34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/infdis\/jiae307","article-title":"Recurrent Group B Streptococcus Neonatal Invasive Infections, France, 2007-2021","volume":"231","author":"Sbaa","year":"2025","journal-title":"J Infect Dis"},{"key":"2026070807100833000_111.4.F310.35","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102748","article-title":"Intrapartum antibiotic prophylaxis to prevent Group B streptococcal infections in newborn infants: a systematic review and meta-analysis comparing various strategies","volume":"74","author":"Panneflek","year":"2024","journal-title":"EClinicalMedicine"},{"key":"2026070807100833000_111.4.F310.36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamapediatrics.2018.4826","article-title":"Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015","volume":"173","author":"Nanduri","year":"2019","journal-title":"JAMA Pediatr"},{"key":"2026070807100833000_111.4.F310.37","doi-asserted-by":"crossref","unstructured":"Seedat F , Taylor-Phillips S , Seedat F . Universal antenatal culture-based screening for maternal Group B Streptococcus (GBS) carriage to prevent early-onset GBS disease: external review against programme appraisal criteria for the UK National Screening Committee. 2016. doi:10.1136\/jech-2017-SSMAbstracts.34","DOI":"10.1136\/jech-2017-SSMAbstracts.34"},{"key":"2026070807100833000_111.4.F310.38","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-022-02375-3"},{"key":"2026070807100833000_111.4.F310.39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/jmwh.13245","article-title":"Impact of Intrapartum Antibiotic Prophylaxis for Group B Streptococcus on the Term Infant Gut Microbiome: A State of the Science Review","volume":"66","author":"Garcia","year":"2021","journal-title":"J Midwifery Womens Health"},{"key":"2026070807100833000_111.4.F310.40","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1016\/j.jaip.2021.07.046","article-title":"Anaphylaxis and Pregnancy: A Systematic Review and Call for Public Health Actions","volume":"9","author":"Carra","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026070807100833000_111.4.F310.41","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S2352-4642(21)00022-5","article-title":"Mortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: a national matched cohort study","volume":"5","author":"Horv\u00e1th-Puh\u00f3","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"2026070807100833000_111.4.F310.42","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/ciac318","article-title":"Comparison of Neurodevelopmental Outcomes in Children With Group B Streptococcal Sepsis and Meningitis","volume":"75","author":"Davies","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026070807100833000_111.4.F310.43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2147\/CLEP.S506809","article-title":"Risk of Depression and Anxiety in Those Who Gave Birth to Children Who Developed Invasive Group B Streptococcal Disease: A Population-Based Cohort Study","volume":"17","author":"Horv\u00e1th-Puh\u00f3","year":"2025","journal-title":"Clin Epidemiol"},{"key":"2026070807100833000_111.4.F310.44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejogrb.2020.10.022","article-title":"Impact of late-onset group B streptococcus infection on families: An observational study","volume":"256","author":"Raybould","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2026070807100833000_111.4.F310.45","unstructured":"Group B Strep Support . The cost of group B strep infection. 2018."},{"key":"2026070807100833000_111.4.F310.46","unstructured":"World Health Organization . WHO recommendation on screening of pregnant women for intrapartum antibiotic prophylaxis for the prevention of early onset group B streptococcus disease in newborns. Geneva World Health Organization, Human Reproduction Programme; 2024.1."},{"key":"2026070807100833000_111.4.F310.47","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2016-311419"},{"key":"2026070807100833000_111.4.F310.48","unstructured":"Routine testing for Group B Streptococcus in pregnancy (GBS3 trial). ISRCTN Registry. Available: https:\/\/www.isrctn.com\/ISRCTN49639731 [Accessed 17 Sep 2025]."},{"key":"2026070807100833000_111.4.F310.49","doi-asserted-by":"crossref","first-page":"127575","DOI":"10.1016\/j.vaccine.2025.127575","article-title":"Progress towards a Group B streptococcal vaccine \u2013 where are we now?","volume":"62","author":"Thorn","year":"2025","journal-title":"Vaccine (Auckl)"},{"key":"2026070807100833000_111.4.F310.50","doi-asserted-by":"crossref","first-page":"127131","DOI":"10.1016\/j.vaccine.2025.127131","article-title":"Clinical and regulatory development strategies for GBS vaccines intended for maternal immunisation in low- and middle-income countries","volume":"58","author":"Le Doare","year":"2025","journal-title":"Vaccine (Auckl)"},{"key":"2026070807100833000_111.4.F310.51","doi-asserted-by":"crossref","first-page":"D52","DOI":"10.1016\/j.vaccine.2013.02.029","article-title":"Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants","volume":"31","author":"Madhi","year":"2013","journal-title":"Vaccine (Auckl)"},{"key":"2026070807100833000_111.4.F310.52","unstructured":"St George\u2019s, University of London . Development of a serocorrelate of protection against invasive group B streptococcus disease. Report no.: NCT04735419 . 2023. Available: https:\/\/clinicaltrials.gov\/study\/NCT04735419 [Accessed 17 Sep 2025]."},{"key":"2026070807100833000_111.4.F310.53","unstructured":"GBS vaccine clinical trial tracker. Available: https:\/\/www.path.org\/our-impact\/resources\/gbs-vaccine-clinical-trial-tracker\/ [Accessed 17 Sep 2025]."}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2025-330108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:10:47Z","timestamp":1783519847000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/archdischild-2025-330108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,7,8]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/archdischild-2025-330108"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2025-330108","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]}}}